Cargando…
A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
BACKGROUND: Early screening for prostate cancer (PCA) remains controversial because of overdiagnosis and overtreatment of clinically insignificant cancers. Even though a number of diagnostic tests have been developed to improve on PSA testing, there remains a need for a more informative non-invasive...
Autores principales: | Brikun, Igor, Nusskern, Deborah, Decatus, Andrew, Harvey, Eric, Li, Lin, Freije, Diha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029393/ https://www.ncbi.nlm.nih.gov/pubmed/29988684 http://dx.doi.org/10.1186/s13148-018-0524-x |
Ejemplares similares
-
An expanded biomarker panel for the detection of prostate cancer from urine DNA
por: Brikun, Igor, et al.
Publicado: (2019) -
A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients
por: Brikun, Igor, et al.
Publicado: (2014) -
Improved urine DNA methylation panel for early bladder cancer detection
por: Fang, Qixun, et al.
Publicado: (2022) -
Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
por: Ye, Lie-Fu, et al.
Publicado: (2020) -
Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015)